Evidence map›Paper›PMID 36840915›Full record

ArticleThe patient2023

Focus Groups to Inform the Development of a Patient-Reported Outcome Measure (PROM) for Temporomandibular Joint Disorders (TMDs).

Emily Elstad, Fraser D Bocell, Tamika Cowans Owens, Dilani Logan, Emily Melluso, Claire Viscione, San Keller, Allen Chen, Jessica Weinberg, Veronica Sansing-Foster and 10 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The patient, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Emily ElstadAmerican Institutes for Research, 1400 Crystal Drive, 10th Floor, Arlington, VA, 22202-3289, USA.
Fraser D BocellFood and Drug Administration, Center for Devices and Radiological Health, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA. fraser.bocell@fda.hhs.gov.ORCID 0000-0002-2943-2662
Tamika Cowans OwensAmerican Institutes for Research, 1400 Crystal Drive, 10th Floor, Arlington, VA, 22202-3289, USA.
Dilani LoganAmerican Institutes for Research, 1400 Crystal Drive, 10th Floor, Arlington, VA, 22202-3289, USA.
Emily MellusoAmerican Institutes for Research, 1400 Crystal Drive, 10th Floor, Arlington, VA, 22202-3289, USA.
Claire ViscioneAmerican Institutes for Research, 1400 Crystal Drive, 10th Floor, Arlington, VA, 22202-3289, USA.
San KellerAmerican Institutes for Research, 1400 Crystal Drive, 10th Floor, Arlington, VA, 22202-3289, USA.
Allen ChenFood and Drug Administration, Center for Devices and Radiological Health, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA.
Jessica WeinbergFood and Drug Administration, Center for Devices and Radiological Health, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA.
Veronica Sansing-FosterFood and Drug Administration, Center for Devices and Radiological Health, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA.
Leah RoyceFood and Drug Administration, Center for Devices and Radiological Health, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA.
Phillip WoodsFood and Drug Administration, Center for Devices and Radiological Health, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA.
Andrew I SteenFood and Drug Administration, Center for Devices and Radiological Health, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA.
Adriana Van IneveldThe TMJ Association, P.O. Box 26770, Milwaukee, WI, 53226, USA.
Michelle ReardonThe TMJ Association, P.O. Box 26770, Milwaukee, WI, 53226, USA.
Allen CowleyThe TMJ Association, P.O. Box 26770, Milwaukee, WI, 53226, USA.
John KusiakThe TMJ Association, P.O. Box 26770, Milwaukee, WI, 53226, USA.
Deanne ClareThe TMJ Association, P.O. Box 26770, Milwaukee, WI, 53226, USA.
Terrie CowleyThe TMJ Association, P.O. Box 26770, Milwaukee, WI, 53226, USA.
Michelle E TarverFood and Drug Administration, Center for Devices and Radiological Health, 10903 New Hampshire Ave, Silver Spring, MD, 20993-0002, USA.
Center for Devices and Radiological Health · USAmerican Institutes for Research · USTMJ Association · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding symptoms of temporomandibular joint disorders (TMDs) can help doctors and patients document, monitor, and manage the disease and help researchers evaluate interventions. Patients with TMDs experience symptoms ranging from mild to severe, primarily in the head and neck region. This study describes findings from formative patient focus groups to capture, categorize, and prioritize symptoms of TMDs towards the development of a patient-reported outcome measure (PROM).

methodsWe conducted ten focus groups with 40 men and women with mild, moderate, and severe TMD. Focus groups elicited descriptions of symptoms and asked participants to review a list of existing patient-reported outcomes (PROs) from the literature and patient advisor input and speak to how those PROs reflect their own experience, including rating their importance.

resultsWe identified 52 distinct concepts across six domains: somatic, physical, social, sexual, affective, and sleep. Focus groups identified the ability to chew and eat; clicking, popping, and other jaw noises; jaw pain and headaches; jaw misalignment or dislocation; grinding, clenching, or chewing, including at night; and ear sensations as most important. Participants with severe TMDs more often reported affective concepts like depression and shame than did participants with mild or moderate TMDs.

conclusionFindings support PROM item development for TMDs, including selecting existing PROMs or developing new ones that reflect patients' lived experiences, priorities, and preferred terminology. Such measures are needed to increase understanding of TMDs, promote accurate diagnosis and effective treatment, and help advance research on TMDs.

Indexed as

Temporomandibular Joint DisordersFemaleFocus GroupsHumansMaleSleepTreatment Outcome

Identifiers

PMID36840915
PMCPMC9961303
OpenAlexW4321996654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.